Key points are not available for this paper at this time.
Open access to the scientific literature remains a controversial area. To adequately summarize the different arguments and opinions on the matter could easily fill an entire book (Willinsky, 20051). In this commentary, we present the perspective of an open access publisher. Since BioMed Central
Cockerill et al. (2006) studied this question.